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Infection of an implanted intracardiac lead (cardiac pace-
maker or defibrillator) is a rare occurrence but is associated
with a poor prognosis, and fatal outcomes are related to
delays in diagnosis and treatment.1 We report herein a case
of pacemaker pocket infection associated with sepsis caused
by Pseudomonas aeruginosa in a patient with non-obstructive
hypertrophic cardiomyopathy.
A 28-year-old female with non-obstructive hypertrophic
cardiomyopathy was admitted to the Department of Car-
diology, Government General Hospital in May 2006. A single
chamber pacemaker lead tip was positioned in the right
ventricular apex and the pacemaker generator was placed
in the left infraclavicular subcutaneous pocket. The sub-
cutaneous facial planes and the surrounding musculature
were sutured and post-operative antibiotic treatment was
given with cefotaxime, gentamicin, and metronidazole.
The suture was removed and the patient was discharged
10 days after implantation. The patient was readmitted a
month later with a history of fever of one-week duration,
dyspnea, and chest pain. On physical examination, her
blood pressure was 80/60 mmHg, her pulse rate 80 per
minute, she had raised jugular venous pressure, and body
temperature was 101 8F (38 8C). Clinical examination of the
surgical wound showed a complete erosion of pacemaker
pocket, with a purulent discharge on the left side of the
chest with exposed pacemaker metal hardware. The white
blood cell count was 16  109 cells/l with 72% neutrophils,
20% lymphocytes, and 8% eosinophils. The hemoglobin was
12.2 g/dl, the platelet count was 236  109/l, and erythro-
cyte sedimentation rate was 23 mm for 1 hour. The elec-
trocardiogram showed a properly functioning single
chamber pacemaker with periods of spontaneous and paced
rhythm. A trans-thoracic echocardiogram showed mild
regurgitation of the tricuspid valve without detectable
vegetation at valves, leads, atrial and ventricular endo-
cardium.
The purulent discharge from the eroded pocket abscess
and three samples of blood were drawn for culture after
which antibiotic therapy was started, which consisted of
cefoperazone—sulbactam (1 g twice daily), metronidazole
(50 mg every 6 h), and gentamicin (80 mg twice daily). The
pacemaker was explanted from the eroded pocket and a
thorough surgical cleaning of the infected pocket was
performed. Specimens for culture were processed by
standard protocols2 and all of them grew a Gram-negative
bacillus that was identified as Pseudomonas aeruginosa.
Antimicrobial susceptibility testing was performed by
the Kirby—Bauer disc diffusion method as per CLSI recom-
mendations.3 The isolate was found to be susceptible to
gentamicin, amikacin, ciprofloxacin, levofloxacin, ofloxa-
cin, ceftriaxone, cefotaxime, cefoperazone—sulbactam,
piperacillin—tazobactam, and imipenem. The patient
responded well to treatment and was afebrile within
72 hours after initiation of therapy. Antibiotic treatment
was continued for 2 weeks. Repeat blood cultures were
sterile. The pacemaker was reimplanted in the right pec-
toral region. The patient had an uneventful recovery andwas
discharged from hospital.The majority of pacemaker infections occur in the pace-
maker generator pocket. Several sources for infection have
been postulated. One possible source is contamination of the
pocket at the time of device implantation. Staphylococcus
spp is the most frequently isolated microorganism in pace-
maker site infections. Pacemaker infection associated with
Gram-negative microorganisms and fungi are rarely encoun-
tered.4—6 Pseudomonas spp are ubiquitous and have the
ability to survive in extreme environments. They are impor-
tant causes of nosocomial infections with a greater propen-
sity of invading human hosts in the presence of foreign bodies
and post-surgical states. The majority of isolates are multi-
drug resistant, however our isolate was sensitive to several
antibiotics.7 Management with partial atrial lead removal
and contralateral pacemaker implantation may occasionally
result in recurrence of infection.8 Removal of all hardware is
required when there is relapsing bacteremia in spite of
antibiotic therapy.
Medical devices have extended the lifespan of many
patients, however infections related to these devices are
also common and can be severe and life threatening. The
development of new biomaterials and use of vaccines in high-
risk patients may reduce the risk of infection.
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Figure 1 CT scan showing the mass at presentation.Tuberculosis of the pancreas mimicking carci-
noma
The HIV/AIDS pandemic has affected the South African popu-
lation more than most. Tuberculosis (TB) is endemic in South
Africa and this has been severely aggravated by the advent of
AIDS.1,2 Tuberculosis presents in many guises, some common,
some extremely rare. Often, it is only a high index of suspi-
cion that helps make the diagnosis. We present herein a
patient who presented with obstructive jaundice and a mass
in the head of the pancreas, which resolved on anti-TB
treatment, to serve as a caveat to others.
A 33-year-old female was referred to the surgery depart-
ment of the Pretoria Academic Hospital. She complained of
pain in the right hypochondrium, which had been present for
two weeks. The pain was constant and not affected by meals.
She described her stools as being green in color. The patient
weighed 75 kg, which was her approximate expected weight
for height. She was jaundiced. None of the typical constitu-
tional symptoms of tuberculosis were reported on question-
ing, nor was the patient observed to have fever, nausea,
vomiting or night sweats during her hospital stay. There was
nomedical or surgical history of any note. The patient did not
have any known TB contacts. The patient had oral candidia-
sis. There was a 3 cm mass in her left supraclavicular fossa
fixed to underlying structures. A vague epigastric mass was
felt on clinical examination, which was otherwise unremark-
able — the liver appeared to be of normal size and the
gallbladder was not clinically palpable. Vital signs were
normal throughout her hospital stay.
On admission, the patient’s full blood count was normal,
the liver functions were typical of obstructive jaundice
(bilirubin 117.3 mmol/l, ALP 401 IU/l, gGT 462 IU/l, ALT
64 IU/L, AST 57 IU/L), and the CRP was 90 mg/l. Chest
X-ray was normal. Due to the endemic nature of tuberculosis
in South Africa, a purified protein derivative (PPD) skin test
was not performed. Pancreatic enzymes were not tested.
Serum albumin was 24 g/l on admission.
Abdominal ultrasound showed a large cystic mass in the
head of the pancreas. Intra- and extra-hepatic bile ducts
were dilated. A computed tomography (CT) scan confirmed
the presence of a 4.47  3.37  4.4 cm cystic mass in the
head of the pancreas (Figure 1). The mass was thick-walled
with septae. There was no sign of intra-abdominal lym-
phadenopathy. In consultation with the radiologists, a
preliminary diagnosis of a periampullary carcinoma was
made.Fine needle aspiration (FNA) of the supraclavicular
lymph node was performed. This yielded copious numbers
of TB bacilli. The patient also tested positive for HIV, with a
CD4 count of 164. A thorough examination showed no other
sites of tuberculous involvement. Due to the patient’s
general condition, as well as the diagnosis of tuberculosis
based on the supraclavicular lymph node, a CT-guided FNA
of the mass in the pancreas was not attempted. It was
considered possible that the mass in the pancreas was due
to TB.
The patient was started on anti-TB treatment with a
standard regimen of rifampin, isoniazid and pyrazinamide.
She was also referred for antiretroviral therapy. Rapid
improvement of symptoms and resolution of the jaundice
followed within a period of several days, as demonstrated by
the rapid normalization of liver function tests (Table 1). The
CT scan was repeated a month later and showed that the
maximal diameter of the cystic mass had decreased to
3.71 cm and the bile ducts were no longer dilated
(Figure 2). Treatment for TB, as well as highly active anti-
retroviral therapy (HAART) was continued. Liver functions
had normalized at the one-year follow-up.
In a landmark study in 1941, Auerbach reported on 1656
autopsies on patients with TB.3 Of these, 297 had miliary TB
(18%) and only 14 of the 297 cases had any evidence of
pancreatic involvement (4.7%). In 1977 Bhansali reported
